Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Intangibles (2022 - 2024)

Eton Pharmaceuticals' Change in Intangibles history spans 3 years, with the latest figure at $8.1 million for Q4 2024.

  • For Q4 2024, Change in Intangibles rose 947.61% year-over-year to $8.1 million; the TTM value through Sep 2025 reached $8.1 million, up 207.19%, while the annual FY2024 figure was $10.0 million, 1188.77% up from the prior year.
  • Change in Intangibles for Q4 2024 was $8.1 million at Eton Pharmaceuticals, up from $1.9 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $8.1 million in Q4 2024 and bottomed at $750000.0 in Q1 2022.
  • The 3-year median for Change in Intangibles is $1.9 million (2024), against an average of $2.7 million.
  • The largest YoY upside for Change in Intangibles was 947.61% in 2024 against a maximum downside of 947.61% in 2024.
  • A 3-year view of Change in Intangibles shows it stood at $2.1 million in 2022, then crashed by 63.53% to $775000.0 in 2023, then surged by 947.61% to $8.1 million in 2024.
  • Per Business Quant, the three most recent readings for ETON's Change in Intangibles are $8.1 million (Q4 2024), $1.9 million (Q1 2024), and $775000.0 (Q4 2023).